Credit Suisse »

Cardiol Therapeutics Inc- foreign shares owned by Credit Suisse

Quarter-by-quarter ownership of Cardiol Therapeutics Inc- foreign (CRDL) shares owned by Credit Suisse from 13F filings

Historical chart of Credit Suisse investment in Cardiol Therapeutics Inc- foreign

Tip: Access up to 7 years of quarterly data

All positions including Cardiol Therapeutics Inc- foreign held by Credit Suisse consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cardiol Therapeutics Inc- foreign by Credit Suisse

Quarter filed Position value Share count Share price at filing
2023-12-31 $88k 80k 1.10
2023-09-30 $62k 50k 1.24

More positions owned by Credit Suisse

Microsoft Corporation (MSFT)
Apple (AAPL)
Ubs Group SHS (UBS)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
UnitedHealth (UNH)
Tesla Motors (TSLA)
Alcon Ord Shs (ALC)
Visa Com Cl A (V)
Meta Platforms Cl A (META)
Johnson & Johnson (JNJ)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)

View all positions for Credit Suisse

Top funds holding Cardiol Therapeutics Inc- foreign

MMCAP International Inc. SPC
Tejara Capital
AXS Investments
Lion Street Advisors
Cambridge Investment Research Advisors
Bank Of Montreal
We Are One Seven
Credit Suisse
Advisor Group Holdings
Marble Harbor Investment Counsel
Royal Bank of Canada
Goldman Sachs Group
Two Sigma Advisers
Private Ocean
Citadel Advisors

View all funds holding Cardiol Therapeutics Inc- foreign